Suanfarma CDMO - CDMO/CMO

Suanfarma, founded in 1993, is a B2B life science partner committed to health and innovation through the development, manufacturing, and distribution of high-quality ingredients for the pharmaceutical industry, all in a sustainable and innovative manner.

At Suanfarma API, we collaborate with pharmaceutical partners worldwide, focusing on the development, scaling, manufacturing, and commercialization of Active Pharmaceutical Ingredients (APIs). With a strong network of 12 local offices strategically placed across the globe, we provide services to over 400 customers in more than 70 countries.

At Suanfarma CDMO, we offer comprehensive, end-to-end solutions for the development and commercialization of intermediates and drug substances for small molecules. We specialize in supporting pharmaceutical, biotech, and healthcare companies, offering innovative services...

Address: C. de Einstein, 8, 28108, Alcobendas, Madrid
Spain

Local time:

Visit website

Integrated innovative platforms for Technology Transfer (TT&GO®)

Fermentation, purification, and chemical synthesis technologies on the same site

Scalability from Laboratory and Pilot to Industrial scales

Drug Substance

small

medium

large

Interested in audit report?

Response time:

Employees:

600

Established in:

1993

Services

Drug Substance (CDMO/CRO)

Intermediates

Pharmaceutical intermediates are compounds used in the production of APIs. CDMOs play a crucial role in synthesizing, scaling, and ensuring the quality of these intermediate compounds to support efficient drug manufacturing.

Replies quickly

Small Molecule APIs

Small molecule APIs form the backbone of many pharmaceutical drugs due to their low molecular weight and ease of synthesis. They are widely used in treating a range of diseases and are typically produced through chemical synthesis in GMP-compliant facilities.

Replies quickly

Contact Suanfarma CDMO for Contract Services Expertise

Connect with Suanfarma CDMO, a leading pharmaceutical company from Spain. They offer specialized Drug Substance (CDMO/CRO). Contact Suanfarma CDMO for free and discover if they are the perfect partner for your pharmaceutical needs.

Drug Substance (CDMO/CRO)

Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.

Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.

Key Functions of Drug Substance CDMOs/CROs:

API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.
Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.
GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.
Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.
Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.

Explore Leading API CDMOs and CROs

Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.